CardioDx in the News
March 01, 2015Louisiana's Health & Fitness Magazine
Dr. Hector Ventura and Dr. Eiman Jahangir discuss how they are integrating this unique decision-making tool in their cardiology practices at Ochsner Medical Center.
November 18, 2014KESQ-TV & CBS Local 2, La Quinta, CA
A new blood test can detect and prevent Heart Disease. In the United States, Heart Disease is the leading cause of death of all diseases in men and women. "My grandfather passed away from a heart attack," said patient, Theresa Miller. "I had an uncle who also passed away at a young age from a heart attack. My father had heart disease that was diagnosed at a relatively young age in his 40s."
October 22, 2014GenomeWeb
Results of a single-center retrospective study demonstrate the benefits of using the Corus CAD test in an African American population. By ruling out obstructive CAD early in the work-up, the Corus CAD test was able to help clinicians avoid unnecessary referrals to cardiology or advanced cardiac testing when their patient’s symptoms were due to non-cardiac causes.
April 02, 2014GenomeWeb
A prospective study in the primary care setting found CardioDx's obstructive coronary artery disease rule-out test, Corus CAD, significantly affected physician decision-making, changing doctors' treatment strategy in more than half of the patients studied.
June 14, 2013KABC-TV, Los Angeles, CA
Corus CAD is the only sex-specifc diagnostic blood test for obstructive coronary artery disease that accounts for the critical biological differences between men and women. Cardiologist and Corus CAD user Dr. Alan Grossman introduces us to one of his female patients, who received the sex-specific blood test.
April 25, 2013Fierce Medical Devices
CardioDx has entered into an agreement granting to Core Diagnostics India the exclusive right to market and sell CardioDx’s Corus CAD diagnostic test in India.
February 26, 2013Men's Fitness
Corus CAD by CardioDx is a gene expression test that uses messenger RNA from a gene set in blood cells to determine whether or not patients have coronary artery blockages. Patients are given a simple blood test that delivers a score on a scale of one to 40.
February 04, 2013Cath Lab Digest
talks with interventional cardiologist Daniel T. Fontenot, MD, FACC about the Corus CAD test which assesses whether or not a stable, non-diabetic patient’s symptoms are due to obstructive coronary artery disease (CAD).
October 23, 2012KGO Bay Area News
CardioDx has developed a new technology that could save thousands of patients from having unnecessary tests for heart disease. At the same time it could also help doctors pinpoint those with the highest risk.
October 02, 2012Fierce Medical Devices
CardioDx was named to the 2012 Fierce 15 for Corus CAD, a blood-based gene expression test for obstructive coronary artery disease that utilizes cutting-edge science and matches it with a huge unmet need.